Duphalac and Hyperpyrexia - a phase IV clinical study of FDA data
Summary:
We study 10,093 people who take Duphalac (lactulose) or have Hyperpyrexia. No report of Hyperpyrexia is found in people who take Duphalac.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Duphalac?
Duphalac has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 5,152 Duphalac users. Check the latest studies of Duphalac.
What is Hyperpyrexia?
Hyperpyrexia (extremely high fever) is found to be associated with 382 drugs and 528 conditions by eHealthMe. Check the latest studies of Hyperpyrexia.
No report is found.
Do you take Duphalac and have Hyperpyrexia?
- Check whether Hyperpyrexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Duphalac:
- Duphalac (5,152 reports)
Hyperpyrexia treatments and more:
- Hyperpyrexia (4,941 reports)
How severe was Hyperpyrexia and when was it recovered:
Expand to all the drugs that have ingredients of lactulose:
Browse all side effects of Duphalac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperpyrexia:
Browse all the conditions that are associated with Hyperpyrexia:
How the study uses the data?
The study uses data from the FDA. It is based on lactulose (the active ingredients of Duphalac) and Duphalac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Meropenem and Oliguria for Women aged 50-59 - a second ago
- Meropenem and Urine Output - Decreased for Women aged 50-59 - a second ago
- Cyramza and Taxol drug interactions for men aged 60+ - 2 seconds ago
- How effective is Midodrine Hydrochloride for Postural Orthostatic Tachycardia Syndrome? - 8 seconds ago
- Could Lipitor cause Post Thrombotic Syndrome? - 15 seconds ago
- Could Prednisone cause Pharyngeal Ulceration? - 31 seconds ago
- Xeljanz and Nightmares for Men aged 50-59 - 32 seconds ago
- Xeljanz and Vivid Nightmare for Men aged 50-59 - 32 seconds ago
- Xeljanz and Nightmare for Men aged 50-59 - 32 seconds ago
- Xeljanz and Dreams - Bad for Men aged 50-59 - 33 seconds ago